Clinical trial
Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
NCT00234897 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00234897 |
|---|---|
| Title | Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis |
| Official title | Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO) |
| Acronym | HERO |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | adalimumab |
| Enrollment | 1,938 |
| Start date | Aug 1, 2004 |
| First posted | Oct 10, 2005 |
| Last update posted | Aug 29, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: